0% found this document useful (0 votes)
19 views6 pages

Year Company Name PUS NS CCE Cceus

This document contains financial data for Aarti Drugs Ltd. from 2001 to 2013. It includes key metrics such as net sales, compensation to employees, marketing and R&D expenses, assets, liabilities, and ratios such as compensation to sales, marketing to sales, and leverage. The descriptive variables provide definitions for the metrics and explain formulas for calculated ratios. The dependent and independent variables are identified for regression analysis with gross profit margin as the target variable to be modeled using asset size, leverage, cost structure and investment ratios as explanatory factors.

Uploaded by

vinesh81
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
19 views6 pages

Year Company Name PUS NS CCE Cceus

This document contains financial data for Aarti Drugs Ltd. from 2001 to 2013. It includes key metrics such as net sales, compensation to employees, marketing and R&D expenses, assets, liabilities, and ratios such as compensation to sales, marketing to sales, and leverage. The descriptive variables provide definitions for the metrics and explain formulas for calculated ratios. The dependent and independent variables are identified for regression analysis with gross profit margin as the target variable to be modeled using asset size, leverage, cost structure and investment ratios as explanatory factors.

Uploaded by

vinesh81
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
You are on page 1/ 6

Year

Company Name
2001 Aarti Drugs Ltd.
2002 Aarti Drugs Ltd.
2003 Aarti Drugs Ltd.
2004 Aarti Drugs Ltd.
2005 Aarti Drugs Ltd.
2006 Aarti Drugs Ltd.
2007 Aarti Drugs Ltd.
2008 Aarti Drugs Ltd.
2009 Aarti Drugs Ltd.
2010 Aarti Drugs Ltd.
2011 Aarti Drugs Ltd.
2012 Aarti Drugs Ltd.
2013 Aarti Drugs Ltd.

PUS
0.15
0.16
0.14
0.13
0.15
0.14
0.13
0.14
0.16
0.16
0.13
0.12
0.15

NS
CCE
CCEUS
1,386.70
52.40
0.04
1,602.50
61.70
0.04
1,738.00
69.30
0.04
2,169.50
71.50
0.03
2,414.90
70.80
0.03
2,529.40
75.00
0.03
2,825.10
89.60
0.03
3,107.30
98.80
0.03
3,764.90
112.30
0.03
4,714.30
147.80
0.03
4,964.20
178.90
0.04
6,592.60
231.40
0.04
8,248.40
279.00
0.03

ME

AE
16.10
21.80
20.90
20.00
26.20
20.40
32.00
21.30
41.50
46.30
41.20
52.30
60.90

3.10
7.20
6.90
4.60
3.10
3.50
2.90
2.70
3.50
5.70
5.20
4.70
11.90

TSME
TSMEUS PBDITA
NW
TOL
TA
19.20
0.01
212.10
468.90
906.60 1,429.40
29.00
0.02
259.20
570.60
955.80 1,569.30
27.80
0.02
251.70
583.80 1,112.10 1,812.00
24.60
0.01
287.50
619.70 1,602.00 2,432.00
29.30
0.01
359.70
731.80 1,879.90 2,871.60
23.90
0.01
347.70
850.10 2,318.10 3,433.20
34.90
0.01
370.40
973.00 2,345.60 3,457.60
24.00
0.01
424.30 1,090.20 2,693.00 3,957.20
45.00
0.01
594.20 1,201.90 2,457.30 3,867.50
52.00
0.01
749.10 1,411.00 2,415.70 4,086.50
46.40
0.01
652.00 1,565.20 3,306.60 5,159.90
57.00
0.01
815.00 1,764.80 4,026.50 6,126.20
72.80
0.01 1,237.20 2,076.10 4,678.70 7,197.30

LNTA

LEV
7.27
7.36
7.50
7.80
7.96
8.14
8.15
8.28
8.26
8.32
8.55
8.72
8.88

RND
0.63
0.61
0.61
0.66
0.65
0.68
0.68
0.68
0.64
0.59
0.64
0.66
0.65

10.90
21.50
14.80
18.20
20.80
4.20
15.00
25.90
29.50
45.50
43.80
46.30
52.10

RNDUS
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01

Variable
Year
Company Name
PUS
NS
CCE
CCEUS
ME
AE
TSME
TSMEUS
PBDITA
NW
TOL
TA
LNTA
LEV
RND
RNDUS

Description
Year of collecting the data
Name of the company
Gross Profit Upon Sales
Net Sales
Compensation to employees
Compensation to employees Upon Sales
Marketing Expenses
Advertisement Expenses
Total Sales and marketing Expenses
Total Sales and marketing Expenses Upon Sales
Profit before dep, interest, tax and amort.
Net Worth
Total Outside Liabilities
Total Assets
Log of total assets
Leverage
Research and development expenses
Research and development expenses upon sales

Formulae

(PBDITA/Net Sales)

(CCE/Net Sales)

(ME + AE)
(TSME/Net Sales)

(TOL/TA)
(RND/Net Sales)

Dependent Variable
PUS

Explanatory Variables
LNTA, LEV, CCEUS, TSMEUS, RNDUS

You might also like